Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis

Research output: Contribution to journalArticle

12 Scopus citations

Fingerprint Dive into the research topics of 'Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences